Literature DB >> 24477817

Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine treatment.

Mehmet Ozaydin1, Oktay Peker, Dogan Erdogan, Selahaddin Akcay, Habil Yucel, Atilla Icli, Betul M Ceyhan, Recep Sutcu, Bayram A Uysal, Ercan Varol, Abdullah Dogan, Huseyin Okutan.   

Abstract

BACKGROUND: Atrial fibrillation is associated with inflammation and oxidative stress. HYPOTHESIS: Carvedilol and N-acetyl cysteine (NAC) combination decreases inflammation, oxidative stress, and postoperative atrial fibrillation (POAF) rates more than metoprolol or carvedilol.
METHODS: Preoperative and postoperative total oxidative stress (TOS), total antioxidant capacity (TAC), and white blood cells (WBC) were measured in metoprolol, carvedilol, or carvedilol plus NAC groups, and association with POAF was evaluated.
RESULTS: Preoperative TAC, TOS, and WBC levels were similar among the groups. Postoperative TAC levels were lower in the metoprolol group compared with the carvedilol group (1.0 vs 1.4) or the carvedilol plus NAC group (1.0 vs 1.9) and were also lower in the carvedilol group compared with the carvedilol plus NAC group (all P < 0.0001). Postoperative TOS levels were higher in the metoprolol group as compared with the carvedilol (29.6 vs 24.2; P < 0.0001) or the carvedilol plus NAC groups (P < 0.0001), and were also higher in the carvedilol group as compared with the carvedilol plus NAC group (24.2 vs 19.3; P < 0.0001). Postoperative WBC counts were lower in the carvedilol plus NAC group compared with the metoprolol group (12.9 vs 14.8; P = 0.004), were similar between the carvedilol and the metoprolol groups (13 vs 14.8) and between the carvedilol plus NAC group and the carvedilol group (both P > 0.05). Postoperative TAC, TOS, and WBC were associated with POAF.
CONCLUSIONS: Carvedilol plus NAC reduced oxidative stress and inflammation compared with metoprolol and decreased oxidative stress compared with carvedilol. Postoperative TAC, TOS, and WBC were associated with POAF.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24477817      PMCID: PMC6649440          DOI: 10.1002/clc.22249

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  6 in total

Review 1.  Pharmacological strategies for prevention of postoperative atrial fibrillation.

Authors:  Mohit K Turagam; Francis X Downey; David C Kress; Jasbir Sra; A Jamil Tajik; Arshad Jahangir
Journal:  Expert Rev Clin Pharmacol       Date:  2015-03       Impact factor: 5.045

2.  Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation.

Authors:  Christian Pfluecke; Daniel Tarnowski; Lina Plichta; Katharina Berndt; Paul Schumacher; Stefan Ulbrich; Mathias Forkmann; Marian Christoph; David M Poitz; Carsten Wunderlich; Ruth H Strasser; Karim Ibrahim
Journal:  Clin Res Cardiol       Date:  2015-09-28       Impact factor: 5.460

3.  New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis.

Authors:  Ana Pardo Sanz; Luisa Salido Tahoces; Rodrigo Ortega Pérez; Eduardo González Ferrer; Ángel Sánchez Recalde; José Luis Zamorano Gómez
Journal:  Cardiol J       Date:  2020-11-03       Impact factor: 2.737

4.  Improved oxidative status in major abdominal surgery patients after N-acetyl cystein supplementation.

Authors:  Aygun Kuyumcu; Asli Akyol; Zehra Buyuktuncer; M Mahir Ozmen; Halit Tanju Besler
Journal:  Nutr J       Date:  2015-01-06       Impact factor: 3.271

5.  Redox-Activated Signal Transduction Pathways Mediating Cellular Functions in Inflammation, Differentiation, Degeneration, Transformation, and Death.

Authors:  Tetsuro Kamiya; Michael Courtney; Mikko O Laukkanen
Journal:  Oxid Med Cell Longev       Date:  2016-12-22       Impact factor: 6.543

Review 6.  The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor.

Authors:  Rossella D'Oria; Rossella Schipani; Anna Leonardini; Annalisa Natalicchio; Sebastio Perrini; Angelo Cignarelli; Luigi Laviola; Francesco Giorgino
Journal:  Oxid Med Cell Longev       Date:  2020-05-14       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.